• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物疗法:肠道和肝细胞转运体在植物补充剂与药物相互作用中的新兴作用。

Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

机构信息

Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan.

Department of Pharmacy, University of Swabi, Swabi 23340, Pakistan.

出版信息

Molecules. 2017 Oct 21;22(10):1699. doi: 10.3390/molecules22101699.

DOI:10.3390/molecules22101699
PMID:29065448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6151444/
Abstract

In herbalism, botanical supplements are commonly believed to be safe remedies, however, botanical supplements and dietary ingredients interact with transport and metabolic processes, affecting drug disposition. Although a large number of studies have described that botanical supplements interfere with drug metabolism, the mode of their interaction with drug transport processes is not well described. Such interactions may result in serious undesired effects and changed drug efficacy, therefore, some studies on interaction between botanical supplement ingredients and drug transporters such as P-gp and OATPs are described here, suggesting that the interaction between botanical supplements and the drug transporters is clinically significant.

摘要

在草药学中,植物补充剂通常被认为是安全的疗法,然而,植物补充剂和膳食成分会与转运和代谢过程相互作用,影响药物处置。尽管大量研究已经描述了植物补充剂会干扰药物代谢,但它们与药物转运过程相互作用的方式尚未得到很好的描述。这种相互作用可能导致严重的不良反应和药物疗效改变,因此,本文描述了一些关于植物补充剂成分与 P-糖蛋白和有机阴离子转运多肽等药物转运体之间相互作用的研究,表明植物补充剂与药物转运体之间的相互作用具有临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91dc/6151444/04f7386dc898/molecules-22-01699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91dc/6151444/04f7386dc898/molecules-22-01699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91dc/6151444/04f7386dc898/molecules-22-01699-g001.jpg

相似文献

1
Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.植物疗法:肠道和肝细胞转运体在植物补充剂与药物相互作用中的新兴作用。
Molecules. 2017 Oct 21;22(10):1699. doi: 10.3390/molecules22101699.
2
Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.药物与植物性膳食补充剂之间的药代动力学相互作用
Drug Metab Dispos. 2016 Feb;44(2):162-71. doi: 10.1124/dmd.115.066902. Epub 2015 Oct 5.
3
Herbal effects: is your supplement safe and effective?草药功效:你的补充剂安全有效吗?
Johns Hopkins Med Lett Health After 50. 2013 Summer;24(6):6-8.
4
Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements.肠和肝细胞转运体:草药补充剂的治疗效果和药物相互作用。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:399-416. doi: 10.1146/annurev-pharmtox-010716-105010. Epub 2016 Sep 14.
5
Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements.药代动力学草药-药物相互作用(第 1 部分):起源、机制以及植物性膳食补充剂的影响。
Planta Med. 2012 Sep;78(13):1478-89. doi: 10.1055/s-0031-1298273. Epub 2012 Feb 9.
6
Herbal supplements: are they worth the risk?草药补充剂:它们值得冒风险吗?
Johns Hopkins Med Lett Health After 50. 2013 Summer;24(6):5.
7
Dietary supplement use among patients with hepatocellular carcinoma.肝细胞癌患者的膳食补充剂使用情况。
Integr Cancer Ther. 2015 Jan;14(1):35-41. doi: 10.1177/1534735414550038. Epub 2014 Sep 15.
8
Common Herbal Dietary Supplement-Drug Interactions.常见草药膳食补充剂与药物的相互作用。
Am Fam Physician. 2017 Jul 15;96(2):101-107.
9
[Interactions between synthetic drugs used in treatment of selected central nervous system disorders and dietary supplements and herbal drugs].[用于治疗特定中枢神经系统疾病的合成药物与膳食补充剂及草药之间的相互作用]
Psychiatr Pol. 2013 May-Jun;47(3):487-98.
10
Follow that botanical: Challenges and recommendations for assessing absorption, distribution, metabolism and excretion of botanical dietary supplements.追踪植物源膳食补充剂:评估植物源膳食补充剂吸收、分布、代谢和排泄的挑战和建议。
Food Chem Toxicol. 2018 Nov;121:194-202. doi: 10.1016/j.fct.2018.08.062. Epub 2018 Aug 28.

引用本文的文献

1
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma.调节miRNA治疗骨肉瘤的天然产物研究进展
Biology (Basel). 2025 Jan 13;14(1):61. doi: 10.3390/biology14010061.
2
Mechanisms of intestinal pharmacokinetic natural product-drug interactions.肠道药代动力学天然产物-药物相互作用的机制。
Drug Metab Rev. 2024 Aug;56(3):285-301. doi: 10.1080/03602532.2024.2386597. Epub 2024 Aug 12.
3
The Role of Glucose Concentration and Resveratrol in Modulating Neuroinflammatory Cytokines: Insights from an In Vitro Blood-Brain Barrier Model.

本文引用的文献

1
Inhibitory mechanism against oxidative stress of caffeic acid.咖啡酸的抗氧化应激抑制机制。
J Food Drug Anal. 2016 Oct;24(4):695-702. doi: 10.1016/j.jfda.2016.05.003. Epub 2016 Jun 2.
2
Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer.咖啡酸苯乙酯在炎症和癌症治疗应用中的潜在分子靶点。
J Food Drug Anal. 2015 Mar;23(1):11-18. doi: 10.1016/j.jfda.2014.06.001. Epub 2014 Aug 11.
3
Significance of Resveratrol in Clinical Management of Chronic Diseases.白藜芦醇在慢性病临床管理中的意义。
葡萄糖浓度和白藜芦醇在调节神经炎症细胞因子中的作用:体外血脑屏障模型的研究进展。
Med Sci Monit. 2023 Oct 11;29:e941044. doi: 10.12659/MSM.941044.
4
Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay.基于分子对接的 SARS-CoV-2 主蛋白酶小分子抑制剂筛选及酶联免疫吸附实验验证
Comput Biol Chem. 2020 Dec;89:107408. doi: 10.1016/j.compbiolchem.2020.107408. Epub 2020 Oct 23.
5
Pharmacokinetics and bioavailability of hydroxytyrosol are dependent on the food matrix in humans.羟基酪醇的药代动力学和生物利用度取决于人体中的食物基质。
Eur J Nutr. 2021 Mar;60(2):905-915. doi: 10.1007/s00394-020-02295-0. Epub 2020 Jun 10.
6
Preparation of an Antidanofloxacin Monoclonal Antibody and Development of Immunoassays for Detecting Danofloxacin in Meat.达氟沙星单克隆抗体的制备及用于检测肉类中达氟沙星的免疫分析方法的建立
ACS Omega. 2020 Jan 2;5(1):667-673. doi: 10.1021/acsomega.9b03270. eCollection 2020 Jan 14.
7
The Sex-Gender Effects in the Road to Tailored Botanicals.性别的影响在定制植物药的道路上。
Nutrients. 2019 Jul 17;11(7):1637. doi: 10.3390/nu11071637.
Molecules. 2017 Aug 18;22(8):1329. doi: 10.3390/molecules22081329.
4
Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements.肠和肝细胞转运体:草药补充剂的治疗效果和药物相互作用。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:399-416. doi: 10.1146/annurev-pharmtox-010716-105010. Epub 2016 Sep 14.
5
Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells.白藜芦醇通过提高细胞内吉非替尼浓度并触发PC9/G非小细胞肺癌细胞的凋亡、自噬和衰老来克服吉非替尼耐药性。
Sci Rep. 2015 Dec 4;5:17730. doi: 10.1038/srep17730.
6
Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.草药在慢性肝病治疗中的现状:生物学效应、分子靶点及未来展望
Int J Mol Sci. 2015 Dec 2;16(12):28705-45. doi: 10.3390/ijms161226126.
7
Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.姜黄素通过抑制外排转运体MRP2和BCRP影响白藜芦醇的Ⅱ相代谢。
Pharm Res. 2016 Mar;33(3):590-602. doi: 10.1007/s11095-015-1812-1. Epub 2015 Oct 26.
8
Multiple ABC Transporters Efflux Baicalin.多种 ABC 转运蛋白外排黄芩苷。
Phytother Res. 2015 Dec;29(12):1987-90. doi: 10.1002/ptr.5477. Epub 2015 Sep 24.
9
Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro.白藜芦醇通过调节 PEPT1、MDR1 和 MRP2 对贝司他汀在体内和体外的肠吸收的增强作用。
Int J Pharm. 2015 Nov 10;495(1):588-598. doi: 10.1016/j.ijpharm.2015.09.042. Epub 2015 Sep 21.
10
A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives.肝脏保护天然化合物综述:作用机制与临床展望
Arch Toxicol. 2016 Jan;90(1):39-79. doi: 10.1007/s00204-015-1580-z. Epub 2015 Sep 16.